Form 4: Medpace Holdings Exec Reports Stock Option Grant

Medpace Holdings, Inc. reports that Executive Vice President Susan E. Burwig was granted stock options and restricted stock units.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc., received a grant of 10,000 employee stock options and 5,000 restricted stock units (RSUs).
• The stock options have an exercise price of $410.54 and vest on the second anniversary of the grant date, April 24, 2026, contingent on continued employment.
• The RSUs also vest in full on the second anniversary of the grant date, April 24, 2026, subject to continued employment.
• Following these transactions, Burwig beneficially owns 70,484 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine executive compensation adjustments rather than significant financial or strategic news.

Positives

• Grant of stock options and RSUs indicates management's continued incentive and alignment with shareholder value.
• Vesting conditions tied to continued employment suggest a focus on long-term retention and performance.
• Direct beneficial ownership of 70,484 shares shows significant personal investment in the company's success.

Negatives

• The exercise price of $410.54 for the stock options is a significant hurdle that the stock price must surpass for the options to be in-the-money.

Risks

• The value of the stock options and RSUs is subject to market fluctuations and the company's future stock performance.
• Continued employment is a condition for vesting, meaning any departure before the vesting date would result in forfeiture of these awards.

Future Outlook

The future outlook for the granted stock options and RSUs is dependent on Medpace Holdings' stock performance and the continued employment of Susan E. Burwig. The options expire in 2033, providing a long-term incentive.

Industry Context

StockSavvy.ai notes that the granting of stock options and restricted stock units to key executives is a common practice in the contract research organization (CRO) industry to attract, retain, and incentivize talent, aligning their interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The grants align executive interests with long-term shareholder value, but the ultimate impact depends on stock performance.
• Employees: This filing highlights executive compensation practices, which can influence overall employee morale and retention strategies.
• Management: Susan E. Burwig is incentivized to perform and remain with the company to realize the value of her awards.

Next Steps

• Susan E. Burwig must remain employed by Medpace Holdings or one of its subsidiaries until April 24, 2026, for the stock options and RSUs to vest.
• The company's stock price performance will determine the ultimate value of the granted equity awards.

Key Dates

Keywords

Medpace Holdings, MEDP, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Susan E. Burwig, SEC Filing